Form D — Pelthos Therapeutics Inc.
0001919246-26-000142 · filed Nov 16, 2026
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Pharmaceuticals filings
Offering
- Industry
- Pharmaceuticals
- Exemptions
- Rule 506(b)
- Reported offering amount
- $57,500,000
- Reported amount sold
- $57,500,000
- Minimum investment
- $0
- Investors
- 7
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- Pelthos Therapeutics Inc.
- CIK
- 1919246
- Entity
- Corporation
- Jurisdiction
- NEVADA
- Year incorporated
- 2021
- Address
- 4020 Stirrup Creek Drive, Suite 110
Durham, North Carolina 27703 - Phone
- 919-908-2400
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Scott Plesha · Executive OfficerDurham, North Carolina Find on LinkedIn ↗
-
John M. Gay · Executive OfficerDurham, North Carolina Find on LinkedIn ↗
-
Sai Rangarao · Executive OfficerDurham, North Carolina Find on LinkedIn ↗
-
Richard Baxter · DirectorDurham, North Carolina Find on LinkedIn ↗
-
Peter Greenleaf · Executive OfficerDurham, North Carolina Find on LinkedIn ↗
-
Ezra Friedberg · DirectorDurham, North Carolina Find on LinkedIn ↗
-
Todd Davis · DirectorDurham, North Carolina Find on LinkedIn ↗
-
Richard Malamut · DirectorDurham, North Carolina Find on LinkedIn ↗
-
Matthew Pauls · DirectorDurham, North Carolina Find on LinkedIn ↗
-
Andrew Einhorn · DirectorDurham, North Carolina Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗